Inquiry

* Please note that all of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

CDK8-IN-6

Cat. No.: IBDI-432294

CDK8-IN-6 (compound 9) is a potent cyclin-dependent kinase 8 (CDK8) inhibitor with an Kd of 13 nM. CDK8-IN-6 shows cytotoxicity for MOLM-13, OCI-AML3, MV4-11, NRK and H9c2 cells with IC50s of 11.2, 7.5, 8.6, 20.5, 12.5-25 µM, respectively. CDK8-IN-6 has the potential for the research of AML-cancer.

Size (Solid):

Product Details

Target CDK
Molecular Weight 413.04
SMILES C[[email protected]@]12C(C3=CC(Cl)=CN=C3)=CC[[email protected]@]1([H])[[email protected]]4([H])CC[[email protected]@]5([H])C[[email protected]](N(C)C)CC[[email protected]]5(C)[[email protected]@]4([H])CC2

Storage & Handling

Shipping Room temperature in continental US. May vary elsewhere.
Storage Please store the product under the recommended conditions in the Certificate of Analysis.
Regulatory Status This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.
! For research use only, not intended for any clinical use.